摘要
目的:点评2018年度湛江中心人民医院门诊中药处方不合理的原因,为临床合理开具中药处方提供依据.方法:随机在合理用药监测系统(Prescription Automatic Screening System,PASS)抽取门诊中药处方2100张进行专家点评.结果:抽取的2100张处方中,不合格处方有470张,不合格率为22.38%;处方年龄分布以31~60岁年龄段的患者居多,共计1603张(占76.33%);处方药味数以7~13味中药和14~19味中药的处方份数最多,共计1695分(占80.71%);单味药和2味药的处方份数最少,仅占总处方的比例分别为0.48%和1.10%.结论:中药处方基本合格,开展中药处方点评并加强相关干预措施,有助于保证中药处方的科学规范,提升医院用药的有效性和安全性,保障患者的生命安全.
Objective To review the reasons for the unreasonable prescription of Chinese medicine in our hospital in 2018,and to find out the specific intervention measures to provide a basis for clinically prescribed Chinese medicine prescriptions.Methods 2100 outpatient prescriptions were randomly selected from the Prescription Automatic Screening System(PASS)for expert evaluation.Results In the 2100 prescriptions,470 were unqualified,with a failure rate of 22.38%.The age distribution of prescriptions was mostly in patients aged 31~60,with a total of 1603 prescriptions(76.33%).The number of prescriptions of 7~13 kinds of traditional Chinese medicine and 14~19 kinds of traditional Chinese medicine is the largest,with a total of 1695 points(80.71%).The number of prescriptions of single and two medicines was the least,accounting for 0.48%and 1.10%of the total prescriptions respectively.Conclusion The prescription of traditional Chinese medicine in our hospital is basically qualified.Carrying out the prescription review of traditional Chinese medicine and strengthening relevant intervention measures will help to ensure the scientific standard of Chinese medicine prescription,improve the effectiveness and safety of hospital medication,and ensure the safety of patients.
作者
邓义卫
黄良
钟邱
罗旭明
李少婷
罗少玲
DENG Yiwei;HUANG Liang;ZHONG Qiu;LUO Xuming;LI Shaoting;LUO Shaoling(Zhanjiang Central People’s Hospital,Zhanjiang 524000,China)
出处
《中国民族民间医药》
2019年第12期114-116,共3页
Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词
中药处方
点评
不合理原因
干预措施
Chinese Medicine Prescription
Unreasonable Reasons
Comments
Interventions
作者简介
邓义卫(1973-),男,汉族,本科,主管中药师,研究方向为中药学。E-mail:deng232218@163.com
